Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-045481
Filing Date
2013-08-14
Accepted
2013-08-14 10:01:49
Documents
11
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v351795_10-q.htm 10-Q 246959
2 EXHIBIT 31.1 v351795_ex31-1.htm EX-31.1 7421
3 EXHIBIT 31.2 v351795_ex31-2.htm EX-31.2 7422
4 EXHIBIT 32.1 v351795_ex32-1.htm EX-32.1 4823
5 EXHIBIT 32.2 v351795_ex32-2.htm EX-32.2 4708
  Complete submission text file 0001144204-13-045481.txt   2850293

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT enmd-20130630.xml EX-101.INS 197989
7 XBRL TAXONOMY EXTENSION SCHEMA enmd-20130630.xsd EX-101.SCH 23124
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE enmd-20130630_cal.xml EX-101.CAL 21673
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE enmd-20130630_def.xml EX-101.DEF 119392
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE enmd-20130630_lab.xml EX-101.LAB 176886
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enmd-20130630_pre.xml EX-101.PRE 138948
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
ENTREMED INC (Filer) CIK: 0000895051 (see all company filings)

EIN.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-20713 | Film No.: 131035429
SIC: 2836 Biological Products, (No Diagnostic Substances)